BAIN CAPITAL SEEKS $5B VALUATION FOR DATA CENTRE STAKE
AI DESK■ 1 MIN READ
THU, APR 23, 2026■ AI-SUMMARIZED FROM 3 SOURCES ▸ TIMELINE
Bain Capital is pursuing a sale of at least 40% of Bridge Data Centres, valuing the Singapore-based infrastructure builder at $5 billion. The transaction marks a significant exit opportunity for the investment firm.
The U.S. investment firm is exploring strategic options to divest its majority stake in Bridge Data Centres (BDC), one of Southeast Asia's leading data infrastructure operators. A 40% or larger stake sale at the proposed $5 billion valuation would substantially reduce Bain's ownership while generating substantial returns.
Bridge Data Centres operates critical infrastructure across the region, serving growing demand from cloud providers, enterprises, and digital services. The sector has attracted heightened interest from institutional investors seeking exposure to data centre assets amid accelerating cloud adoption and AI computing demands.
The divestment process remains in early stages. Potential buyers could include infrastructure funds, sovereign wealth funds, or strategic operators seeking to expand regional data centre portfolios. No timeline for completion has been announced.
Bain Capital acquired its stake in Bridge Data Centres as part of broader infrastructure investment strategy focused on essential digital assets across Asia-Pacific markets.
■ MORE FROM THE STARTUPS DESK
Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.
MAY 29— AI Desk
Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.
MAY 29— AI Desk
Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.
MAY 29— AI Desk
H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.
MAY 29— Industry Desk